Evidence map›Paper›PMID 42653703›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Dangguibuxue Decoction Attenuated AA I-Induced Renal Fibrosis: Integrating Network Pharmacology and Experimental Validation.

Suyan Liu, Jing Meng, Yong Zhao, Chunying Li, Yan Yi, Jiayin Han, Yushi Zhang, Chen Pan, Xingwen Wang, Liping Wang and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Suyan LiuState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Jing MengBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Yong ZhaoBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Chunying LiBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Yan YiBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Jiayin HanState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Yushi ZhangBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.ORCID 0000-0002-3268-0421
Chen PanBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Xingwen WangBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Liping WangBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Feng GaoBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Xingnan YueBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Jingwen WuBeijing Key Laboratory of Psychoactive Substances Discovery and Control in Chinese Herbal Medicines, Beijing 100700, China.
Hongmei LiState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID 0009-0001-7739-0196
Aihua LiangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Funding

Fundamental Research Funds for the Central Public Welfare Research Institutes ZZ13-YQ-055; ZXKT22044; ZXKT25036National Natural Science Foundation of China 82304851; 82174073; 82192913Scientific and technological innovation project of China Academy of Chinese Medical Sciences CI2023E002
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dangguibuxue decoctionhypoxiaphosphorylationrenal fibrosisrutinTGF-β/Smad

Identifiers

PMID42653703
PMCPMC13516570

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.